Cipla to invest in Cipla Medpro South Africa Proprietary

03 Feb 2025 Evaluate

Cipla is all set to invest around ZAR 900 million in equity share capital of Cipla Medpro South Africa Proprietary (CMSA), a wholly-owned subsidiary of the Company in South Africa.

The investment will be utilised to reduce inter-group debt and improve the capital structure of CMSA and its subsidiaries. The investment is expected to be completed on or before February 28, 2025 or such other date mutually agreed between the parties.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.


Cipla Share Price

1463.15 46.85 (3.31%)
11-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1687.55
Dr. Reddys Lab 1109.15
Cipla 1463.15
Lupin 1969.05
Zydus Lifesciences 868.25
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...